Current News

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES TWENTY PERCENT REVENUE INCREASE FOR THREE MONTHS ENDED MARCH 31, 2002

Retractable Technologies' CEO Thomas J. Shaw Applauds Senate Anti-Trust Hearing On Hospital Purchasing Cartels Urges Panel to "Restore Free Market Competition to the Healthcare Industry"

Investrend Research Announces Investment Opinion: Retractable Technologies `Strong Buy,' $11.00 12 Mo Target Issued by Investrend Analyst Justin Canivet, CFA

Retractable Technologies, Inc. Hires Halliburton Investor Relations to Implement Strategic Financial Communications Program

Retractable Technologies, Inc. Announces Significant Revenue Increase for 2001

Retractable Technologies, Inc. Receives Contribution From CEO and Spouse Through Royalty Transaction

Britain's National Health Service Places Retractable Technologies' Vanishpoint Safety Needle Devices On Supplies List

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RECORD REVENUES FOR THE NINE MONTHS AND FUNDING OF $5 MILLION

Joint Purchasing Corp. to Distribute Retractable Technologies' VanishPoint Safety Syringes

Retractable Technologies' VanishPoint Safety Needle Devices Approved for Sale in Japan

18 19 20 21 22 23 24

<< < > >>

Retractable Technologies Inc. - Privacy